267 related articles for article (PubMed ID: 37246525)
1. The Role of Fascin-1 in Human Urologic Cancers: A Promising Biomarker or Therapeutic Target?
Zhang N; Bian Q; Gao Y; Wang Q; Shi Y; Li X; Ma X; Chen H; Zhao Z; Yu H
Technol Cancer Res Treat; 2023; 22():15330338231175733. PubMed ID: 37246525
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA in prostate, bladder, and kidney cancer.
Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
[TBL] [Abstract][Full Text] [Related]
3. Nuclear p53 overexpression in bladder, prostate, and renal carcinomas.
Sinik Z; Alkibay T; Ataoglu O; Biri H; Sözen S; Deniz N; Karaoglan U; Bozkirli I
Int J Urol; 1997 Nov; 4(6):546-51. PubMed ID: 9477181
[TBL] [Abstract][Full Text] [Related]
4. Biologic significance of fascin expression in clear cell renal cell carcinoma: systematic analysis of primary and metastatic tumor tissues using a tissue microarray technique.
Zigeuner R; Droschl N; Tauber V; Rehak P; Langner C
Urology; 2006 Sep; 68(3):518-22. PubMed ID: 16979727
[TBL] [Abstract][Full Text] [Related]
5. Association of EMMPRIN and fascin expression in renal cell carcinoma: correlation with clinicopathological parameters.
Tsai WC; Sheu LF; Nieh S; Yu CP; Sun GH; Lin YF; Chen A; Jin JS
World J Urol; 2007 Mar; 25(1):73-80. PubMed ID: 17021824
[TBL] [Abstract][Full Text] [Related]
6. Establishing Fascin over-expression as a strategic regulator of neoplastic aggression and lymph node metastasis in oral squamous cell carcinoma tumor microenvironment.
Routray S; Kheur S; Chougule HM; Mohanty N; Dash R
Ann Diagn Pathol; 2017 Oct; 30():36-41. PubMed ID: 28965626
[TBL] [Abstract][Full Text] [Related]
7. Fascin regulates prostate cancer cell invasion and is associated with metastasis and biochemical failure in prostate cancer.
Darnel AD; Behmoaram E; Vollmer RT; Corcos J; Bijian K; Sircar K; Su J; Jiao J; Alaoui-Jamali MA; Bismar TA
Clin Cancer Res; 2009 Feb; 15(4):1376-83. PubMed ID: 19228738
[TBL] [Abstract][Full Text] [Related]
8. GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma.
Xue Y; Wu G; Liao Y; Xiao G; Ma X; Zou X; Zhang G; Xiao R; Wang X; Liu Q; Long D; Yang J; Xu H; Liu F; Liu M; Xie K; Huang R
Br J Cancer; 2014 Apr; 110(9):2250-60. PubMed ID: 24595000
[TBL] [Abstract][Full Text] [Related]
9. The prometastatic ribosomal S6 kinase 2-cAMP response element-binding protein (RSK2-CREB) signaling pathway up-regulates the actin-binding protein fascin-1 to promote tumor metastasis.
Li D; Jin L; Alesi GN; Kim YM; Fan J; Seo JH; Wang D; Tucker M; Gu TL; Lee BH; Taunton J; Magliocca KR; Chen ZG; Shin DM; Khuri FR; Kang S
J Biol Chem; 2013 Nov; 288(45):32528-32538. PubMed ID: 24085294
[TBL] [Abstract][Full Text] [Related]
10. Fascin determination in urothelial carcinomas of the urinary bladder: a marker of invasiveness.
Karasavvidou F; Barbanis S; Pappa D; Moutzouris G; Tzortzis V; Melekos MD; Koukoulis G
Arch Pathol Lab Med; 2008 Dec; 132(12):1912-5. PubMed ID: 19061289
[TBL] [Abstract][Full Text] [Related]
11. High fascin-1 expression in colorectal cancer identifies patients at high risk for early disease recurrence and associated mortality.
Tampakis A; Tampaki EC; Nonni A; Kostakis ID; Posabella A; Kontzoglou K; von Flüe M; Felekouras E; Kouraklis G; Nikiteas N
BMC Cancer; 2021 Feb; 21(1):153. PubMed ID: 33579217
[TBL] [Abstract][Full Text] [Related]
12. Fascin-1 as a biomarker and prospective therapeutic target in colorectal cancer.
Adams JC
Expert Rev Mol Diagn; 2015 Jan; 15(1):41-8. PubMed ID: 25370828
[TBL] [Abstract][Full Text] [Related]
13. Fascin overexpression promotes neoplastic progression in oral squamous cell carcinoma.
Alam H; Bhate AV; Gangadaran P; Sawant SS; Salot S; Sehgal L; Dange PP; Chaukar DA; D'cruz AK; Kannanl S; Gude R; Kane S; Dalal SN; Vaidya MM
BMC Cancer; 2012 Jan; 12():32. PubMed ID: 22264292
[TBL] [Abstract][Full Text] [Related]
14. The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update.
Campagna R; Pozzi V; Spinelli G; Sartini D; Milanese G; Galosi AB; Emanuelli M
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439880
[TBL] [Abstract][Full Text] [Related]
15. Fascin is a predictor for invasiveness and recurrence of urothelial carcinoma of bladder.
Bi J; Chen X; Zhang Y; Li B; Sun J; Shen H; Kong C
Urol Oncol; 2012 Sep; 30(5):688-94. PubMed ID: 20888270
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
17. The role of fascin-1 in the pathogenesis, diagnosis and management of respiratory related cancers.
Zhang N; Gao Y; Bian Q; Wang Q; Shi Y; Zhao Z; Yu H
Front Oncol; 2022; 12():948110. PubMed ID: 36033434
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the desmoplastic reaction and invading ability in invasive ductal carcinoma of the breast and prostatic adenocarcinoma based on the expression of heat shock protein 47 and fascin.
Nese N; Kandiloglu AR; Simsek G; Lekili M; Ozdamar A; Catalkaya A; Coskun T
Anal Quant Cytol Histol; 2010 Apr; 32(2):90-101. PubMed ID: 20701077
[TBL] [Abstract][Full Text] [Related]
19. Fascin-1 enhances experimental osteosarcoma tumor formation and metastasis and is related to poor patient outcome.
Arlt MJ; Kuzmanov A; Snedeker JG; Fuchs B; Silvan U; Sabile AA
BMC Cancer; 2019 Jan; 19(1):83. PubMed ID: 30654764
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA in prostate, bladder, and kidney cancer: a systematic review.
Catto JW; Alcaraz A; Bjartell AS; De Vere White R; Evans CP; Fussel S; Hamdy FC; Kallioniemi O; Mengual L; Schlomm T; Visakorpi T
Eur Urol; 2011 May; 59(5):671-81. PubMed ID: 21296484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
